AI Analysis
AI-generated analysis. Always verify with the original filing.
Omeros reported a net loss of -$3.4M and free cash flow of -$116.2M in FY2025, reflecting ongoing operational cash needs despite strategic transactions reshaping liquidity and pipeline focus.
Key Takeaways
1Net income was -$3.4M, capturing core operating performance amid biotech development costs.
2Net cash provided by operating activities was -$116.1M, driven by working capital changes and non-cash adjustments.
3Capital expenditures were $65K, minimally impacting overall cash position.
4Free cash flow was -$116.2M, calculated as operating cash flow less capital expenditures, highlighting cash burn for operations.